Lymphomatous Meningitis: Symptoms, Prognosis, and Treatment

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the spinal cord and brain. This tissue, the "meninges," protects the nervous system and when it is compromised by LM, the flow of cerebrospinal fluid [CSF] is compromised, resulting in a rapid deterioration of the central nervous system. It should be noted that "meningitis" is a somewhat inaccurate name as it implies inflammation which is not always present.

Incidence

Fewer than 10% of cancer patients with cancer are diagnosed with LM; because LM is a peripheral cancer, often diagnosed by autopsy, it is difficult to state incidence rates with high accuracy. It is known that LM incidence is on the rise, possibly because improved treatment of primary cancers results in more patients who are vulnerable to this condition which is especially prevalent in recurring cancers.

LM is of particular interest to lymphoma patients as some lymphoma patients carry a higher risk for LM than other cancer patients.

Symptoms

Symptoms are generally the result of the obstructed flow CSF by inflammation and/or tumors. They vary widely and do not always raise a "red flag" for LM. Symptoms may include:

  • Pain and seizures (the most common patient-reported symptoms)
  • Headaches (usually associated with nausea, vomiting, lightheadedness)
  • Gait difficulties from weakness or ataxia
  • Memory problems
  • Incontinence
  • Sensory abnormalities

Prognosis

It is generally believed that LM is underdiagnosed because of widely varying symptoms and the fact that it is preceded by other cancers, often in the later stages. If not detected, it usually results in death within four to six weeks. It is not often cured but it is treatable.

Treatment

Both radiation therapy and chemotherapy are indicated for lymphomatous meningitis; sometimes a combination of the two is employed.

In the case of chemotherapy, cytarabine is the first choice. DepoCyt®, a liposome-encapsulated time-release form of cytarabine, is a favored treatment because it is only administered once every two weeks as opposed to multiple times per week for the non-encapsulated form.

 

Sources

Photo: Pexels

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...